Related references
Note: Only part of the references are listed.OPTN/SRTR 2016 Annual Data Report: Pancreas
R. Kandaswamy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized-Controlled MECANO Trial
F. J. Bemelman et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus
H. A. Chakkera et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial
Klemens Budde et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial
J. W. de Fijter et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12
H. H. Hirsch et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Risk of Metabolic Complications in Kidney Transplantation After Conversion to mTOR Inhibitor: A Systematic Review and Meta-Analysis
N. Murakami et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies
Laure-Emmanuelle Croze et al.
TRANSPLANT INTERNATIONAL (2014)
Evidence for Rapamycin Toxicity in Pancreatic beta-Cells and a Review of the Underlying Molecular Mechanisms
Adam D. Barlow et al.
DIABETES (2013)
Profiling Sirolimus-Induced Inflammatory Syndrome: A Prospective Tricentric Observational Study
Fanny Buron et al.
PLOS ONE (2013)
Five-Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study
Y. Lebranchu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus with Cyclosporine After Kidney Transplantation
L. Liefeldt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Advantage of Rapamycin Over Mycophenolate Mofetil When Used With Tacrolimus for Simultaneous Pancreas Kidney Transplants: Randomized, Single-Center Trial at 10 Years
G. Ciancio et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Posttransplant Donor-Specific Anti-HLA Antibodies Negatively Impact Pancreas Transplantation Outcome
D. Cantarovich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients
S. M. Flechner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
Klemens Budde et al.
LANCET (2011)
Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy
S. Brouard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Comparing an Early Corticosteroid/Late Calcineurin-Free Immunosuppression Protocol to a Sirolimus-, Cyclosporine A-, and Prednisone-Based Regimen for Pancreas-Kidney Transplantation
Richard J. Knight et al.
TRANSPLANTATION (2010)
Conversion to Sirolimus Allows Preservation of Renal Function in Kidney and Kidney-Pancreas Allograft Recipients
G. Laham et al.
TRANSPLANTATION PROCEEDINGS (2010)
Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study
Y. Lebranchu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Chronic Calcineurin Inhibitor Nephrotoxicity: Reflections on an Evolving Paradigm
Robert S. Gaston
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Minimization protocols in pancreas transplantation
Diego Cantarovich et al.
TRANSPLANT INTERNATIONAL (2009)
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
Francesco P. Schena et al.
TRANSPLANTATION (2009)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sirolimus versus cyclosporine in kidney recipients receiving Thymoglobulin®, mycophenolate mofetil and a 6-month course of steroids
M. Buechler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation
D Cantarovich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Immunosuppressive drugs for kidney transplantation
PF Halloran
NEW ENGLAND JOURNAL OF MEDICINE (2004)